{"schema_version":"secwatch.filing_event.v1","accession":"0001420720-22-000096","form_type":"8-K","ticker":"IBIO","cik":"0001420720","company_name":"iBio, Inc.","filed_at":"2022-12-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.596667+00:00","generated_at":"2026-06-21T06:44:11.832859+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"iBio closes $3.5M underwritten public offering of common stock and warrants","bullets":["Offering includes 3,365,385 shares (or pre-funded warrants) plus Series A and B warrants at $1.04 per share.","Series A warrants expire 5 years; Series B warrants expire 24 months from issuance, both immediately exercisable.","Gross proceeds ~$3.5M; net proceeds for operating costs, R&D, working capital, and debt payments.","Underwriter H.C. Wainwright partially exercised option for additional warrants to buy up to 1,009,614 shares.","Shareholder votes at Dec 8 annual meeting: elected directors Armstrong and Kropotova, ratified auditor, approved say-on-pay."],"urls":{"canonical":"https://secwatch.observer/filing/0001420720-22-000096","json":"https://secwatch.observer/filing/0001420720-22-000096.json","markdown":"https://secwatch.observer/filing/0001420720-22-000096.md","text":"https://secwatch.observer/filing/0001420720-22-000096.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420720/000142072022000096/0001420720-22-000096-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420720/000142072022000096/ibio-20221208x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T06:44:11.832859+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"49752c8f174c85c6278bdf40e2c9132f038f1b50","claim":"iBio, Inc. shareholders approved Advisory vote on executive compensation at the 2022-12-08 meeting.","evidence_excerpt":"Proposal 3 The stockholders approved, on an advisory, non-binding basis, the compensation of the Company’s named executive officers (\"say-on-pay\"), as disclosed in the Definitive Proxy Statement. The results of the voting for this approved proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 780,830 537,904 28,727 2,552,791","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420720/000142072022000096/0001420720-22-000096-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-08"}],"fact_type":"shareholder_vote"},{"claim_id":"688c40d8de5dedde465203afc04c674efcff02c6","claim":"iBio, Inc. shareholders approved Election of Class II directors at the 2022-12-08 meeting.","evidence_excerpt":"Proposal 1 The following two (2) nominees named as Class II directors of the Company’s Board of Directors, each to serve a three-year term expiring at the 2025 Annual Meeting of Stockholders and until such director’s successor is duly elected and qualified, were elected with the following votes: Name of Director Votes For Withheld Broker Non-Votes 1. Dr. Linda W. Armstrong ​ 1,051,212 ​ 296,249 ​ 0 2. Dr. Alexandra Kropotova 1,027,547 319,914 0 ​","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420720/000142072022000096/0001420720-22-000096-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-08"}],"fact_type":"shareholder_vote"},{"claim_id":"a75a8e5288ebba69404d551096d14426c58a9d27","claim":"iBio, Inc. shareholders approved Ratification of CohnReznick LLP as independent registered public accounting firm for the year ending June 30, 2022 at the 2022-12-08 meeting.","evidence_excerpt":"Proposal 2 The stockholders ratified the appointment of CohnReznick LLP as the Company’s independent registered public accounting firm for the year ending June 30, 2022 based on the votes set forth below: Votes For Votes Against Abstentions Broker Non-Votes 3,226,366 607,132 66,754 0 ​","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420720/000142072022000096/0001420720-22-000096-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-08"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}